# PRospective Multiple Myeloma Impact Study

> **NCT02911571** · NA · ACTIVE_NOT_RECRUITING · sponsor: **SkylineDx** · enrollment: 250 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DEVICE:** MMprofiler SKY92 gene signature

## Key facts

- **NCT ID:** NCT02911571
- **Lead sponsor:** SkylineDx
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-02-27
- **Primary completion:** 2022-04-18
- **Final completion:** 2026-10-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02911571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02911571, "PRospective Multiple Myeloma Impact Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02911571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*